WO2005025595A3 - Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins - Google Patents

Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins Download PDF

Info

Publication number
WO2005025595A3
WO2005025595A3 PCT/US2004/029560 US2004029560W WO2005025595A3 WO 2005025595 A3 WO2005025595 A3 WO 2005025595A3 US 2004029560 W US2004029560 W US 2004029560W WO 2005025595 A3 WO2005025595 A3 WO 2005025595A3
Authority
WO
WIPO (PCT)
Prior art keywords
calcium phosphate
pastes
delivery
osteogenic
osteogenic proteins
Prior art date
Application number
PCT/US2004/029560
Other languages
French (fr)
Other versions
WO2005025595A2 (en
WO2005025595B1 (en
Inventor
Rebecca Li
Howard Seeherman
Hyun Kim
Original Assignee
Wyeth Corp
Etex Corp
Rebecca Li
Howard Seeherman
Hyun Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP04783698A priority Critical patent/EP1675608B1/en
Priority to BRPI0413720-5A priority patent/BRPI0413720A/en
Priority to AU2004272072A priority patent/AU2004272072B2/en
Priority to JP2006526310A priority patent/JP5392981B2/en
Priority to PL04783698T priority patent/PL1675608T3/en
Priority to CN2004800329780A priority patent/CN1878565B/en
Priority to NZ546438A priority patent/NZ546438A/en
Priority to DE602004005477T priority patent/DE602004005477T2/en
Application filed by Wyeth Corp, Etex Corp, Rebecca Li, Howard Seeherman, Hyun Kim filed Critical Wyeth Corp
Priority to CA2537735A priority patent/CA2537735C/en
Priority to SI200430283T priority patent/SI1675608T1/en
Priority to DK04783698T priority patent/DK1675608T3/en
Publication of WO2005025595A2 publication Critical patent/WO2005025595A2/en
Publication of WO2005025595A3 publication Critical patent/WO2005025595A3/en
Publication of WO2005025595B1 publication Critical patent/WO2005025595B1/en
Priority to IL174198A priority patent/IL174198A/en
Priority to NO20061547A priority patent/NO20061547L/en
Priority to HK06108590A priority patent/HK1086199A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Abstract

Osteogenic proteins are delivered via an injectable solid rod or hardenable paste. The formulation comprises a calcium phosphate material, an osteogenic protein, and optional additives and active ingredients such as a bone resorption inhibitor. Methods of making injectable pharmaceutical compositions and methods of using the osteogenic compositions to treat bone defects are also disclosed.
PCT/US2004/029560 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins WO2005025595A2 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CA2537735A CA2537735C (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
BRPI0413720-5A BRPI0413720A (en) 2003-09-12 2004-09-10 injectable calcium phosphate sticks and solid pastes for release of osteogenic proteins
SI200430283T SI1675608T1 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods for delivery of osteogenic proteins
PL04783698T PL1675608T3 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods for delivery of osteogenic proteins
CN2004800329780A CN1878565B (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
NZ546438A NZ546438A (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
DE602004005477T DE602004005477T2 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods for delivery of osteogenic proteins
EP04783698A EP1675608B1 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods for delivery of osteogenic proteins
AU2004272072A AU2004272072B2 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
JP2006526310A JP5392981B2 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of bone morphogenetic proteins
DK04783698T DK1675608T3 (en) 2003-09-12 2004-09-10 Injectable solid calcium phosphate rods for administration of osteogenic proteins
IL174198A IL174198A (en) 2003-09-12 2006-03-09 Compositions for injectable delivery of osteogenic proteins, methods for their preparation and uses thereof
NO20061547A NO20061547L (en) 2003-09-12 2006-04-05 Injectable calcium phosphate solid rods or masses for delivery of osteogenic proteins
HK06108590A HK1086199A1 (en) 2003-09-12 2006-08-02 Injectable calcium phosphate solid rods for delivery of osteogenic proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50249303P 2003-09-12 2003-09-12
US60/502,493 2003-09-12

Publications (3)

Publication Number Publication Date
WO2005025595A2 WO2005025595A2 (en) 2005-03-24
WO2005025595A3 true WO2005025595A3 (en) 2005-10-13
WO2005025595B1 WO2005025595B1 (en) 2005-11-17

Family

ID=34312397

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/029560 WO2005025595A2 (en) 2003-09-12 2004-09-10 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins

Country Status (29)

Country Link
US (2) US7771755B2 (en)
EP (3) EP2374471A1 (en)
JP (1) JP5392981B2 (en)
KR (1) KR20060133961A (en)
CN (2) CN1878565B (en)
AR (1) AR045935A1 (en)
AT (1) ATE357244T1 (en)
AU (1) AU2004272072B2 (en)
BR (1) BRPI0413720A (en)
CA (1) CA2537735C (en)
CO (1) CO5680451A2 (en)
CR (1) CR8299A (en)
CY (1) CY1108012T1 (en)
DE (1) DE602004005477T2 (en)
DK (1) DK1675608T3 (en)
EC (1) ECSP066500A (en)
ES (1) ES2282904T3 (en)
HK (1) HK1086199A1 (en)
IL (1) IL174198A (en)
NO (1) NO20061547L (en)
NZ (1) NZ546438A (en)
PL (1) PL1675608T3 (en)
PT (1) PT1675608E (en)
RU (1) RU2363478C2 (en)
SI (1) SI1675608T1 (en)
TW (1) TW200518767A (en)
UA (1) UA88275C2 (en)
WO (1) WO2005025595A2 (en)
ZA (1) ZA200602079B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3273773B2 (en) 1999-08-12 2002-04-15 イビデン株式会社 Ceramic heater for semiconductor manufacturing / inspection equipment, electrostatic chuck for semiconductor manufacturing / inspection equipment and chuck top for wafer prober
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
ES2282904T3 (en) * 2003-09-12 2007-10-16 Wyeth SOLID BARS OF INJECTABLE CALCIUM PHOSPHATE FOR THE SUPPLY OF OSTEOGENIC PROTEINS.
US7955616B2 (en) 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
ITTO20050549A1 (en) * 2005-08-03 2007-02-04 Consiglio Nazionale Ricerche COMPOSITE MATERIAL INJECTABLE TO BE USED AS A BONUS SUBSTITUTE
KR101105890B1 (en) * 2005-12-14 2012-01-16 에스씨아이엘 테크놀로지 게엠베하 A moldable biomaterial for bone regeneration
KR100829452B1 (en) * 2006-06-13 2008-05-15 (주)코리아 본 뱅크 Bioactive Protein-Calcium Phosphate Composite and the Manufacturing Method of the same
US20100015068A1 (en) * 2006-07-06 2010-01-21 Massachusetts Institute Of Technology Methods and Compositions For Altering Biological Surfaces
DE102006042142A1 (en) * 2006-09-06 2008-03-27 Curasan Ag Phase- and sedimentation-stable, plastically deformable preparation with intrinsic pore formation, for example for filling bone defects or for use as a bone substitute material, and method for their preparation
US8048857B2 (en) * 2006-12-19 2011-11-01 Warsaw Orthopedic, Inc. Flowable carrier compositions and methods of use
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
EP1958649A1 (en) 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor
US20080241256A1 (en) * 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles
FR2948573B1 (en) * 2009-07-31 2011-11-18 Adocia NEW FORM OF ADMINISTRATION OF OSTEOGENIC PROTEIN COMPLEXES
US20110307074A1 (en) * 2010-05-24 2011-12-15 University Of The Witwatersrand, Johannesburg Biomaterials for use in methods of bone replacement therapy
WO2012068135A1 (en) 2010-11-15 2012-05-24 Zimmer Orthobiologics, Inc. Bone void fillers
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
US20160038555A1 (en) * 2011-03-31 2016-02-11 Kang Yell Choi Composition Containing Extracts of the Fruit of Hovenia Dulcis THUNB as an Active Ingredient for Preventing and Treating Bone Diseases
RU2015128609A (en) * 2012-12-19 2017-01-25 КАШИВ ФАРМА, ЭлЭлСи Oversaturated Stabilized Nanoparticles for Weakly Soluble Drugs
KR101443814B1 (en) * 2013-03-28 2014-09-30 주식회사 바이오알파 An injectable composition for bone defects and a preparation method therof
AU2015374114B2 (en) 2014-12-29 2018-07-26 Bioventus, Llc Systems and methods for improved delivery of osteoinductive molecules in bone repair
GB2559761A (en) * 2017-02-16 2018-08-22 Corthotec Ltd Composition for improved bone fracture healing
AU2019339920A1 (en) * 2018-09-14 2021-04-29 Orthocell Limited Artificial periosteum
EP3936165A1 (en) * 2020-07-10 2022-01-12 MedPark Co., Ltd. Method for preparing bone graft composition and bone graft composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047117A1 (en) * 1999-02-10 2000-08-17 Safe Conduct Ab Cannula
WO2001028603A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
WO2001028602A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
WO2002100331A2 (en) * 2001-06-08 2002-12-19 Wyeth Calcium phosphate delivery vehicles for osteoinductive proteins
WO2003099992A2 (en) * 2002-05-17 2003-12-04 Wyeth Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins

Family Cites Families (201)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
CH563767A5 (en) * 1973-01-30 1975-07-15 Pheulpin Jean
US4468464A (en) 1974-11-04 1984-08-28 The Board Of Trustees Of The Leland Stanford Junior University Biologically functional molecular chimeras
DE2657370C2 (en) * 1976-12-17 1982-11-11 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Means for covering and / or filling in bone defects
DE2732848A1 (en) * 1977-07-18 1979-02-08 Schering Ag DIURETHANE, HERBICIDAL AGENTS CONTAINING THESE COMPOUNDS AND THE PROCESS FOR THEIR PRODUCTION
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4619989A (en) 1981-05-05 1986-10-28 The Regents Of The University Of Cal. Bone morphogenetic protein composition
US4455256A (en) * 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4789732A (en) 1980-08-04 1988-12-06 Regents Of The University Of California Bone morphogenetic protein composition
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4294753A (en) 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
PH19942A (en) 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4727028A (en) * 1981-06-22 1988-02-23 Eli Lilly And Company Recombinant DNA cloning vectors and the eukaryotic and prokaryotic transformants thereof
US4394370A (en) * 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4472840A (en) 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
US4474181A (en) 1982-02-18 1984-10-02 Schenck Robert R Method and apparatus for anastomosing small blood vessels
USRE33161E (en) 1982-04-29 1990-02-06 American Dental Association Health Foundation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
USRE33221E (en) 1982-04-29 1990-05-22 American Dental Association Health Foundation Dental restorative cement pastes
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US4434094A (en) * 1983-04-12 1984-02-28 Collagen Corporation Partially purified osteogenic factor and process for preparing same from demineralized bone
EP0128041A3 (en) 1983-06-06 1986-12-03 David Jeston Baylink Polypeptides exhibiting skeletal growth factor activity
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
NZ210699A (en) 1984-01-04 1989-06-28 Int Genetic Eng Isolation of an osteogenic protein of the p3 immunologically related family
US4804744A (en) * 1984-01-04 1989-02-14 International Genetic Engineering, Inc. Osteogenic factors
DK518384A (en) 1984-01-31 1985-07-01 Idaho Res Found VECTOR FOR THE MANUFACTURE OF A GENE PRODUCT IN INSECT CELLS, PROCEDURE FOR ITS MANUFACTURING AND ITS USE
US4608199A (en) 1984-03-20 1986-08-26 Arnold Caplan Bone protein purification process
US4662884A (en) * 1984-04-25 1987-05-05 University Of Utah Research Foundation Prostheses and methods for promoting nerve regeneration
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
US4868161A (en) 1984-06-29 1989-09-19 City Of Hope Method for promoting nerve regeneration
US4843063A (en) * 1984-07-16 1989-06-27 Collagen Corporation Polypeptide cartilage-inducing factors found in bone
US4627982A (en) 1984-07-16 1986-12-09 Collagen Corporation Partially purified bone-inducing factor
DE3588058T3 (en) * 1984-07-16 2005-04-07 Celtrix Pharmaceuticals, Inc., Palo Alto Cartilage-inducing polypeptide factors from bone
ATE78515T1 (en) 1984-10-05 1992-08-15 Genentech Inc DNA, CELL CULTURES AND METHODS FOR HETEROLOGOUS PROTEIN SECRETION AND PERIPLASMIC PROTEIN RECOVERY.
US4769328A (en) 1984-10-12 1988-09-06 Zymogenetics Inc. Expression of biologically active PDGF analogs in yeast
US5187263A (en) * 1984-10-12 1993-02-16 Zymogenetics, Inc. Expression of biologically active PDGE analogs in eucaryotic cells
US4563350A (en) * 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
KR930007429B1 (en) * 1984-12-27 1993-08-10 산도리 가부시기가이샤 Method for purifying interferon
US4886747A (en) 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US4766067A (en) 1985-05-31 1988-08-23 President And Fellows Of Harvard College Gene amplification
US4681763A (en) * 1985-06-11 1987-07-21 University Of Medicine And Dentistry Of New Jersey Composition for stimulating bone growth
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
NZ231899A (en) 1985-10-03 1991-07-26 Genentech Inc Human or porcine inhibin peptide compositions and dna encoding them
US4737578A (en) * 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
DE3764144D1 (en) 1986-04-16 1990-09-13 Asta Pharma Ag SYNERGISTIC COMBINATION OF AMANTADINE AND SELEGILINE.
US4758233A (en) * 1986-04-22 1988-07-19 N.J. Phillips TPY. Limited Cream applicator
NL8601328A (en) 1986-05-23 1987-12-16 Langen Research DEVICE FOR INJECTING MEAT WITH A MASS, PARTICULARLY PASTY MASS.
US6432919B1 (en) * 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5459047A (en) 1986-07-01 1995-10-17 Genetics Institute, Inc. BMP-6 proteins
US5631142A (en) * 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US6150328A (en) * 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5366875A (en) 1986-07-01 1994-11-22 Genetics Institute, Inc. Methods for producing BMP-7 proteins
US5543394A (en) 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5939388A (en) 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US5108922A (en) * 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
US5457092A (en) 1987-07-30 1995-10-10 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Methods of promoting bone growth in mammals comprising administration of modified parathyroid hormone
US5041538A (en) 1987-08-28 1991-08-20 The Salk Institute For Biological Studies Mammalian follistatin
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US5147399A (en) 1988-02-01 1992-09-15 Dellon Arnold L Method of treating nerve defects through use of a bioabsorbable surgical device
IT1215881B (en) 1988-02-16 1990-02-22 Giancarlo Foresti OSTEOTROPIC ACTION SURGICAL AID.
IL89869A0 (en) 1988-04-06 1989-12-15 Collagen Corp Bone-inducing protein
US4968590A (en) 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5011691A (en) * 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5053212A (en) 1988-04-20 1991-10-01 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US5962028A (en) 1988-04-20 1999-10-05 Norian Corporation Carbonated hydroxyapatite compositions and uses
US5129905A (en) 1988-04-20 1992-07-14 Norian Corporation Methods for in situ prepared calcium phosphate minerals
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5071834A (en) 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US5284756A (en) * 1988-10-11 1994-02-08 Lynn Grinna Heterodimeric osteogenic factor
US5106626A (en) 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
US4955892A (en) 1988-10-24 1990-09-11 Louisiana State University Neural cell adhesion protein nerve prosthesis
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US4920962A (en) * 1988-11-23 1990-05-01 Claude Proulx Splint-like element for use in end-to-end nerve suture
US5217867A (en) * 1988-11-30 1993-06-08 The Salk Institute For Biological Studies Receptors: their identification, characterization, preparation and use
WO1990010067A1 (en) 1989-02-23 1990-09-07 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition
ATE162223T1 (en) 1989-03-28 1998-01-15 Genetics Inst OSTEOINDUCTIVE COMPOSITIONS
US4963146A (en) 1989-04-20 1990-10-16 Colla-Tec Incorporated Multi-layered, semi-permeable conduit for nerve regeneration
US5026381A (en) * 1989-04-20 1991-06-25 Colla-Tec, Incorporated Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
JPH03151877A (en) 1989-06-02 1991-06-28 Chiron Corp Bone calcium precipitation factor
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
AU5958090A (en) * 1989-06-29 1991-01-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1
CA2020729A1 (en) 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
JP3045398B2 (en) 1989-09-06 2000-05-29 武田薬品工業株式会社 Proteins, DNAs and their uses
US5236456A (en) * 1989-11-09 1993-08-17 Osteotech, Inc. Osteogenic composition and implant containing same
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
GB8927546D0 (en) 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5166190A (en) 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males
US5256418A (en) 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
US5688678A (en) 1990-05-16 1997-11-18 Genetics Institute, Inc. DNA encoding and methods for producing BMP-8 proteins
DE69132823T2 (en) 1990-05-16 2002-07-18 Genetics Inst BONE AND Cartilage Formation Proton Proteins
US5168050A (en) 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
US5218090A (en) * 1990-06-12 1993-06-08 Warner-Lambert Company EGF receptor truncates
US5364839A (en) 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
US5208219A (en) * 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2102808A1 (en) 1991-05-10 1992-11-11 Hanne Bentz Targeted delivery of bone growth factors
US5229495A (en) * 1991-06-18 1993-07-20 Ludwig Institute For Cancer Research Substantially pure receptor like TGF-β 1 binding molecules and uses thereof
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
US6287816B1 (en) * 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
AU652472B2 (en) 1991-06-25 1994-08-25 Genetics Institute, Llc BMP-9 compositions
US5356629A (en) 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
US5306307A (en) * 1991-07-22 1994-04-26 Calcitek, Inc. Spinal disk implant
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5171579A (en) 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
ATE238417T1 (en) 1991-11-04 2003-05-15 Inst Genetics Llc RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE
SE469653B (en) 1992-01-13 1993-08-16 Lucocer Ab POROEST IMPLANT
KR0172186B1 (en) 1992-02-12 1999-02-01 미하엘 파울리스타 Dna sequences encoding novel growth/differentiation factors
JPH07504106A (en) 1992-02-28 1995-05-11 コラーゲン　コーポレイション Injectable ceramic compositions and methods for their manufacture and use
WO1993019177A1 (en) * 1992-03-18 1993-09-30 The General Hospital Corporation FOUR NOVEL RECEPTORS OF THE TGF-β RECEPTOR FAMILY
IT1259100B (en) * 1992-05-20 1996-03-11 Lanfranco Callegaro USE OF HYDROGELS FOR THE LOCKING OF PROSTHETIC SYSTEMS
IL106278A0 (en) 1992-07-13 1993-11-15 Sumitomo Metal Ind Bone formation-inducing protein
PT662146E (en) 1992-09-03 2000-12-29 Univ California FACTOR THAT AFFECTS DORSAL FABRIC AND COMPOSITIONS
US6221958B1 (en) * 1993-01-06 2001-04-24 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
CA2153653C (en) 1993-01-12 2010-12-07 Se-Jin Lee Growth differentiation factor-9
WO1994015949A1 (en) 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-5
CA2153652A1 (en) 1993-01-12 1994-07-21 Se-Jin Lee Growth differentiation factor-3
US5420243A (en) * 1993-01-26 1995-05-30 Celtrix Pharmaceuticals, Inc. Biologically active TGF-β2 peptides
EP0690873B1 (en) 1993-03-19 2003-06-11 The Johns Hopkins University School Of Medicine Growth differentiation factor-8
GB9308060D0 (en) 1993-04-19 1993-06-02 Cancer Res Campaign Tech Stem cell inhibitor
KR100227406B1 (en) * 1993-05-12 1999-12-01 브루스 엠. 에이센 Bmp-11 composition
WO1994026893A1 (en) 1993-05-12 1994-11-24 Genetics Institute, Inc. Bmp-10 compositions
US5637480A (en) 1993-05-12 1997-06-10 Genetics Institute, Inc. DNA molecules encoding bone morphogenetic protein-10
EP0626451A3 (en) 1993-05-27 1997-11-05 Takeda Chemical Industries, Ltd. Heterodimers of a TGF-beta superfamily
US5447725A (en) 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
JPH09503903A (en) 1993-07-09 1997-04-22 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン Growth differentiation factor-6
EP0717633A4 (en) 1993-07-09 1998-05-20 Univ Johns Hopkins Med Growth differentiation factor-7
KR100329409B1 (en) * 1993-08-26 2002-03-20 브루스 엠. 에이센, 토마스 제이 데스로저 Neural regeneration using human bone morphogenetic proteins
US5455041A (en) 1993-09-13 1995-10-03 Research Foundation Of State University Of New York At Buffalo Method for inducing periodontal tissue regeneration
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
EP0725796A4 (en) 1993-10-08 1999-12-01 Univ Johns Hopkins Growth differentiation factor-10
CA2175049A1 (en) 1993-10-28 1995-05-04 Timothy Ringeisen Improved process and device for treating and healing a bone void
US5399677A (en) * 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
US6027919A (en) * 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
PT733109E (en) 1993-12-07 2006-07-31 Genetics Inst Llc MORPHOGENETIC PROTEINS OF 0SS0S PMO-12 AND PMO-13 AND THEIR COMPOSITIONS FOR TENDAO INDUCTION
US5556767A (en) 1993-12-22 1996-09-17 Human Genome Sciences, Inc. Polynucleotide encoding macrophage inflammatory protein γ
EP0741783B1 (en) 1993-12-30 2009-03-18 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing hedgehog-like proteins
JPH07250688A (en) 1994-01-28 1995-10-03 Sagami Chem Res Center New human c-dna coding tgf-beta superfamily protein
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
WO1996001845A1 (en) 1994-07-08 1996-01-25 The Johns Hopkins University School Of Medicine Growth differentiation factor-11
ATE196147T1 (en) 1994-07-13 2000-09-15 Univ Johns Hopkins Med GROWTH DIFFERENTIATION FACTOR-12
US5520923A (en) * 1994-09-19 1996-05-28 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5545616A (en) 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
US5693779A (en) 1994-11-08 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Production and use of anti-dorsalizing morphogenetic protein
US6281332B1 (en) 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
ES2093593T1 (en) 1995-05-05 1997-01-01 Hoffmann La Roche RECOMBINANT OBESE PROTEINS (OB).
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US6117456A (en) 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
ES2440441T3 (en) * 1995-06-05 2014-01-29 Genetics Institute, Llc Use of bone morphogenetic proteins for healing and repair of connective tissue junctions
US5674292A (en) * 1995-06-07 1997-10-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
WO1997022308A1 (en) 1995-12-18 1997-06-26 Degussa Aktiengesellschaft Medical implant
US5700774A (en) 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
EP0907721A1 (en) 1996-05-28 1999-04-14 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
US5813411A (en) 1996-08-20 1998-09-29 Menlo Care, Inc. Method of deforming tissue with a swollen hydrogel
US5965403A (en) 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
EP0941079B1 (en) * 1996-10-16 2007-12-19 Etex Corporation Bioceramic compositions
JPH10151188A (en) * 1996-11-21 1998-06-09 Yamanouchi Pharmaceut Co Ltd Implant for ossification
AU6245898A (en) * 1997-01-21 1998-08-07 Genetics Institute Inc. Injectable formulations for treatment of osteoporotic bone
US20020098222A1 (en) * 1997-03-13 2002-07-25 John F. Wironen Bone paste
US6034062A (en) * 1997-03-13 2000-03-07 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-9 compositions and their uses
US6001352A (en) 1997-03-31 1999-12-14 Osteobiologics, Inc. Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor
US5972368A (en) 1997-06-11 1999-10-26 Sdgi Holdings, Inc. Bone graft composites and spacers
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
US6004937A (en) 1998-03-09 1999-12-21 Genetics Institute, Inc. Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
IT1302534B1 (en) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl INJECTABLE, BIOCOMPATIBLE AND BIODEGRADABLE COMPOSITIONS INCLUDING AT LEAST A DERIVATIVE OF HYALURONIC ACID, CHONDROGENIC CELLS, FOR
JP4211108B2 (en) 1999-01-13 2009-01-21 生化学工業株式会社 High viscoelastic injection device
DE29914313U1 (en) * 1999-08-14 2000-02-24 Augmen Tech Gmbh Reaction systems for implantation in the human and animal body as a bone replacement Contain calcium and phosphorus
DE19938704C1 (en) * 1999-08-14 2001-10-31 Ivoclar Vivadent Ag Process for the production of reaction systems for implantation in the human and animal body as a bone substitute, which i.a. Contain calcium and phosphorus
US6599516B1 (en) * 2000-09-14 2003-07-29 Etex Corporation Malleable implant containing solid element that resorbs or fractures to provide access channels
ES2282904T3 (en) * 2003-09-12 2007-10-16 Wyeth SOLID BARS OF INJECTABLE CALCIUM PHOSPHATE FOR THE SUPPLY OF OSTEOGENIC PROTEINS.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047117A1 (en) * 1999-02-10 2000-08-17 Safe Conduct Ab Cannula
WO2001028603A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
WO2001028602A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
WO2002100331A2 (en) * 2001-06-08 2002-12-19 Wyeth Calcium phosphate delivery vehicles for osteoinductive proteins
WO2003099992A2 (en) * 2002-05-17 2003-12-04 Wyeth Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins

Also Published As

Publication number Publication date
KR20060133961A (en) 2006-12-27
WO2005025595A2 (en) 2005-03-24
EP1772154A2 (en) 2007-04-11
EP2374471A1 (en) 2011-10-12
DK1675608T3 (en) 2007-07-09
CY1108012T1 (en) 2013-09-04
CN1878565A (en) 2006-12-13
PL1675608T3 (en) 2007-11-30
NZ546438A (en) 2010-07-30
CN101897974A (en) 2010-12-01
CN1878565B (en) 2011-01-12
CR8299A (en) 2008-11-26
EP1675608B1 (en) 2007-03-21
JP5392981B2 (en) 2014-01-22
DE602004005477D1 (en) 2007-05-03
CO5680451A2 (en) 2006-09-29
EP1675608A2 (en) 2006-07-05
DE602004005477T2 (en) 2007-12-13
TW200518767A (en) 2005-06-16
AU2004272072A1 (en) 2005-03-24
US8507008B2 (en) 2013-08-13
ECSP066500A (en) 2006-10-10
ES2282904T3 (en) 2007-10-16
NO20061547L (en) 2006-06-01
UA88275C2 (en) 2009-10-12
RU2006105911A (en) 2007-10-20
AU2004272072B2 (en) 2010-07-08
ATE357244T1 (en) 2007-04-15
IL174198A (en) 2010-05-31
BRPI0413720A (en) 2006-10-17
IL174198A0 (en) 2006-08-01
US7771755B2 (en) 2010-08-10
AR045935A1 (en) 2005-11-16
SI1675608T1 (en) 2007-08-31
US20100273706A1 (en) 2010-10-28
ZA200602079B (en) 2008-11-26
CA2537735A1 (en) 2005-03-24
RU2363478C2 (en) 2009-08-10
US20050089579A1 (en) 2005-04-28
WO2005025595B1 (en) 2005-11-17
PT1675608E (en) 2007-05-31
JP2007505133A (en) 2007-03-08
EP1772154A3 (en) 2011-09-07
CN101897974B (en) 2013-09-25
CA2537735C (en) 2018-07-24
HK1086199A1 (en) 2006-09-15
AU2004272072A8 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
WO2005025595A3 (en) Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
WO2003099992A3 (en) Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
WO2002074234A3 (en) Method and composition for treatment of skeletal dysplasias
WO2005074453A3 (en) Rapid-hardening calcium phosphate cement compositions
HK1084015A1 (en) Stable pharmaceutical compositions of 2-aza-bicyclo3.3.0 -octane-3- carboxylic acid derivatives 2-
CA2383580A1 (en) Magnesium ammonium phosphate cements, their production and use
WO2003015612A3 (en) Materials and methods to promote repair of nerve tissue
AU2002231355A1 (en) Injectable vertebral augmentation composition and method
AU2002319091A1 (en) Method for producing a bioactive bone cement and bone cement kit
WO1998043685A3 (en) Bone cement paste containing an antibiotic
AU7566601A (en) Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
IL159714A (en) Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac
EA200602187A1 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING
WO2002099037A3 (en) Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
AU2003251728A1 (en) Placental growth factor as a target for the treatment of osteoporosis
AU2821200A (en) Matrix protein compositions for grafting
BR0213041A (en) Injectable bone filler, syringe, and methods for preparing an injectable bone filler and repairing a bone defect
AU2002241270A1 (en) Compositions for delivering biologically active drug and method of using the same
ATE329613T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING GROWTH HORMONES INHIBITORS OR THEIR BIOLOGICALLY ACTIVE FRAGMENTS FOR THE TREATMENT OF UTERINE MYOMAS
Hyun-chang et al. Effects of enamel matrix protein and β-tricalcium phosphate in surgically created gap defect model of dogs: pilot study

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480032978.0

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
B Later publication of amended claims

Effective date: 20051005

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/002384

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2004272072

Country of ref document: AU

Ref document number: 2537735

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 12006500500

Country of ref document: PH

Ref document number: 174198

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2006526310

Country of ref document: JP

Ref document number: 200602079

Country of ref document: ZA

Ref document number: 1020067004974

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: CR2006-008299

Country of ref document: CR

ENP Entry into the national phase

Ref document number: 2004272072

Country of ref document: AU

Date of ref document: 20040910

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004272072

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 06031152

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: 546438

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2004783698

Country of ref document: EP

Ref document number: 1200600574

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 2006105911

Country of ref document: RU

Ref document number: 915/KOLNP/2006

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2004783698

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0413720

Country of ref document: BR

WWP Wipo information: published in national office

Ref document number: 1020067004974

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 2004783698

Country of ref document: EP